Podcast appearances and mentions of Wallace H Coulter

Since recording this episode, Dr. Karmella Haynes has joined the faculty in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech School of Engineering and Emory University School of Medicine. At the time of recording, Karmella was an Assistant Professor in the Ira A. Fulton School of Biological and Health Systems Engineering at Arizona State University. She was also a senior judge for the International Genetically Engineered Machine Competition. Karmella studies synthetic biology, which involves synthesizing DNA outside of a cell and designing those new pieces of DNA so that they can be used for different purposes like stopping cancer cells from growing or helping stimulate tissue regeneration. She enjoys engaging her creative side within the lab as well as outside of the lab. When she is not working, Karmella likes to look at art and to paint paint with oil or acrylic on canvas. She received her Ph.D. in Molecular Genetics from Washington University in St. Louis. Prior to joining the faculty at ASU, Karmella was awarded a Howard Hughes Medical Institute Teaching and Research fellowship at Davidson College, followed by an NIH postdoctoral fellowship at Harvard Medical School. Karmella joined us for an interview to tell us all about her journey through life and science.

Dr. Ajit Yoganathan – The Wallace H. Coulter Distinguished Faculty Chair in Biomedical Engineering & Regents' Professor at The Georgia Institute of Technology – joins Innovators to talk about his history in biomedical engineering and the background on the field as a field of higher education. Dr. Yoganathan and host Dr. Rick Skinner also conclude their conversation talking about how biomedical engineering could be a "catalyst" to solve problems like COVID-19. According to Dr. Yoganathan, his Cardiovascular Fluid Mechanics Lab at Georgia Tech "focuses on understanding complex cardiovascular problems using fundamental engineering and science. The main objective of my lab is to provide answers to life-saving clinical questions using engineering approaches.” Dr. Yoganathan earned his bachelor's degree from the University of London in 1973 and his Ph.D. in chemical engineering from the California Institute of Technology in 1978. His lab has evaluated (directly or indirectly) all prosthetic heart valves in use in the United States since 1975. Innovators is a podcast production of Harris Search Associates. The show is produced by Grant Burkhardt.  *The views and opinions shared by the guests on Innovators do not necessarily reflect the views of the interviewee's institution or organization.*

In this episode of Behind the Bench, Lisandra de Castro Bras (East Carolina University) and Jonathan Kirk (Loyola University Chicago) talk with Michael Sayegh, an MD/PhD student in the joint Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech. A rotation project with Hee Cheol Cho at Georgia Tech culminated in a first-author publication in AJP-Heart and Circ in June 2019. When we talked with Michael to get the scoop behind his science, we were struck by his humility and gratitude. Our conversation uncovers the catalyst for Michael to pursue becoming a physician scientist, the sometimes-daunting amount of training this involves, and of course, how all of this relates to Harry Potter. Michael’s personal story as an immigrant from Aleppo, Syria, who used a dial-up connection to apply to Harvard and Yale, shows where perseverance, determination and good luck can lead. If anything, we could all use an inspirational story right about now. Michael N. Sayegh, Natasha Fernandez, and Hee Cheol Cho Strength-duration relationship as a tool to prioritize cardiac tissue properties that govern electrical excitability Am J Physiol Heart Circ Physiol, published June 14, 2019. DOI: doi.org/10.1152/ajpheart.00161.2019

Dr. Machelle Pardue is a Research Career Scientist at the Atlanta VA Medical Center and a Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech. She received her Bachelor’s degree in Zoology from the University of Wyoming, her PhD  in Vision Science and Biology from the University of Waterloo, and her post-doctoral training at Loyola School of Medicine and Hines VA Hospital. She then came to the Atlanta VA Medical Center and joined faculty at Emory and later Georgia Tech. In this episode, Dr. Pardue shares with us her experience in training and at the VA, and how she runs her lab to help her students reach their full potential. Credits: Our thanks to Dr. Pardue for being on the podcast. Host: Bejan Saeedi Co-Host and Audio Engineer – Joe Behnke Executive Producer and Social Media Coordinator – Carey Jansen Executive Producer – Michael Sayegh Associate Producer – Josh Owens Faculty Advisor – Dr. Brian Robinson Twitter: @behindthescope_ Instagram: @behindthemicroscopepod Facebook: @behindthemicroscope1 Website: behindthemicroscope.com

In this episode of Research Realized, Kirsten Leute speaks with Elias Caro, VP of Technology Development at the Wallace H. Coulter Foundation and President and Founder of Biocomx. The Coulter Foundation provides university based translational research grants to establish a business-like process to accelerate academic innovations to the marketplace. Elias is currently president and founder of Biocomx, a non-for-profit organization dedicated to training biomedical innovators in commercialization.

Old Drugs, New Tricks: Putting an End to Traditional Eye Drops Presenter: Morgan Fedorchak Director  Ophthalmic Biomaterials Laboratory   Glaucoma is the second leading cause of blindness worldwide, expected to affect up to 3 million Americans by 2020. One of the main risk factors in glaucoma is an unsafe increase in intraocular pressure (IOP).  IOP reduction in patients with glaucoma is typically accomplished through the administration of medicated eye drops several times daily, the difficult and frequent nature of which contributes to patient adherence rates estimated to be as low as 30%.  Newer drug delivery methods for glaucoma aimed at improving patient adherence require clinician administration of invasive injections or implants. This talk will encompass the rational design and testing of a variety of controlled release systems for delivery of ocular drugs as well as the many significant considerations for translating these technologies to the clinic where they may benefit patients. In particular, discussion will focus on our team’s development of a completely unique formulation that provides one month of therapeutic levels of glaucoma medication from a noninvasive eye drop. We believe that this new treatment method may have the ability to overcome the issues inherent to traditional eye drop medication while avoiding the need for more invasive techniques.   Morgan Fedorchak is an Assistant Professor of Ophthalmology, Chemical Engineering, and Clinical and Translational Science at the University of Pittsburgh and the director of the Ophthalmic Biomaterials Laboratory. She attended Carnegie Mellon University where she obtained her B.S. in both Chemical Engineering and Biomedical Engineering in 2006. She later earned her PhD in bioengineering at the University of Pittsburgh in 2011 under Dr. William Federspiel studying hemofiltration and medical devices. Subsequently, she was awarded a fellowship from the Fox Center for Vision Restoration to participate in a collaboration between Dr. Steve Little and Dr. Joel Schuman as a postdoctoral researcher in March of 2011. This work formed the basis for the development of a patent pending drug delivery system for glaucoma that was recently featured in The Wall Street Journal. Her research is currently supported by the National Eye Institute, the Cystinosis Research Foundation, the University of Pittsburgh Center for Medical Innovation, and the Wallace H. Coulter Foundation. Recorded Monday, September 12, 2016 at Carnegie Science Center in Pittsburgh, PA.

Interview of Prof. David Nathan, Professor of Pediatrics and Medicine at the Dana Farber Cancer Institure and Childrens Hospital Boston, MA / The Winner of Wallace Coulter Award Lifetime, shares his view on 'Winner of the Wallace H. Coulter Award for Lifetime Achivement in Hematology: Changes I have seen in hematology practice.' conducted by Shaun McCann, Chair of EHATol Unit, Member of EHA Education Committee.

Interview of Prof. David Nathan, Professor of Pediatrics and Medicine at the Dana Farber Cancer Institure and Childrens Hospital Boston, MA / The Winner of Wallace Coulter Award Lifetime, shares his view on 'Winner of the Wallace H. Coulter Award for Lifetime Achivement in Hematology: Changes I have seen in hematology practice.' conducted by Shaun McCann, Chair of EHATol Unit, Member of EHA Education Committee.

In Podcast 30, we meet Ajit Yoganathan, PhD, Regents' Professor, Associate Chair for Research, and the Wallace H. Coulter Distinguished Faculty Chair in Biomedical Engineering at Georgia Institute of Technology. Dr. Yoganathan and his colleagues are focusing on the development artificial heart valves and the use of novel instrumentation such as Doppler ultrasound [...]